Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,958Revenue (TTM) $M37.2Net Margin (%)-784.0Altman Z-Score14.5
Enterprise Value $M5,765EPS (TTM) $-7.1Operating Margin %-742.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-784.0Higher ROA y-yY
Price/Book31.510-y EBITDA Growth Rate %--Quick Ratio5.5Cash flow > EarningsY
Price/Sales1435-y EBITDA Growth Rate %--Current Ratio5.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-89.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-188.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M51.4ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with TSRO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
TSRORon Baron 2016-06-30 Add$37.21 - $84.05
$ 116.00160%Add 85.00%3,700
TSRORon Baron 2016-03-31 Buy $32.01 - $52.32
$ 116.00189%New holding2,000
TSRODavid Swensen 2015-12-31 Sold Out -0.08%$40.35 - $52.91
$ 116.00142%Sold Out0
TSRODavid Swensen 2015-09-30 Buy 0.08%$38.97 - $65.8
$ 116.00112%New holding6,238
TSROLeon Cooperman 2015-06-30 Sold Out -0.05%$50.84 - $64.65
$ 116.00102%Sold Out0
TSROLeon Cooperman 2015-03-31 Buy 0.05%$36.62 - $61.41
$ 116.00146%New holding50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TSRO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

TSRO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Huber Martin H. Jr.SVP & Chief Medical Officer 2016-09-22Sell408$108.127.29view
English Edward CV.P.Finance and Administration 2016-09-08Sell7,000$88.5431.01view
Hanke Jeffrey H.Executive VP, R&D and CSO 2016-08-30Sell29,166$86.0434.82view
Hanke Jeffrey H.Executive VP, R&D and CSO 2016-06-30Sell12,500$74.3556.02view
English Edward CVP of Finance & Administration 2016-06-10Sell7,000$40.75184.66view
Weller Harry R10% Owner 2016-03-18Buy1,420,858$35.19229.64view
Viswanathan Ravi10% Owner 2016-03-18Buy1,420,858$35.19229.64view
SANDELL SCOTT D10% Owner 2016-03-18Buy1,420,858$35.19229.64view
MOTT DAVID MDirector, 10% Owner 2016-03-18Buy1,420,858$35.19229.64view
KERINS PATRICK J10% Owner 2016-03-18Buy710,429$35.19229.64view

Quarterly/Annual Reports about TSRO:

News about TSRO:

Articles On GuruFocus.com
Major Second Quarter Purchases for Cohen include Tesaro, Pernix Jul 20 2016 
Steven Cohen Hits Another Home Run in Oncology Jul 07 2016 
David Swensen Bets on Antero Resources Mar 10 2016 
David Swensen's Transactions Show Diversity of Portfolio Nov 19 2015 

More From Other Websites
Tesaro to Announce Third-Quarter 2016 Financial Results on November 3, 2016 Oct 20 2016
Tesaro to Announce Third-Quarter 2016 Financial Results on November 3, 2016 Oct 20 2016
Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO Oct 12 2016
Tesoro Soars on Cancer Drug Results (TSRO) Oct 11 2016
​Analysts hike outlook for Waltham’s Tesaro after ovarian cancer drug data Oct 11 2016
Tesaro Bolts On Ovarian Cancer Win Vs. AstraZeneca, AbbVie Oct 10 2016
Street Talk: MAT, AEO & more Oct 10 2016
Analyst: Three things are pushing Mylan higher Oct 10 2016
Tesaro: Priced for a Takeover? Oct 10 2016
Even High-Flying Tesaro and Its Ovarian Cancer Drug Has a Bear Thesis. Here It Is, Explained Oct 10 2016
Here’s Why Mylan, Diamondback Energy, TESARO and Two Other Stocks Are Surging Today Oct 10 2016
Analysts Chase Tesaro Targets and Ratings Higher Oct 10 2016
Tesaro upgraded by BofA/Merrill Oct 10 2016
Tesaro's ovarian cancer drug benefits all patients in study Oct 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)